“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan

Yu-Chun Lie

Research output: Contribution to conference › Paper › peer-review

Original languageEnglish
StatePublished - 2019

Fingerprint Dive into the research topics of '“Novel Targeted Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) by Dual-Inhibition and Multiple-Inhibition of the ERBB family,” Donald Y.C. Lie, Paul E. Lie, Tam Q. Nguyen, and Lukman Tijani, Proc. 32nd In’l Conf. Medical, Medicine and Health Sciences (MMHS-2019) January 17-18, 2019 Taipei, Taiwan'. Together they form a unique fingerprint.

Cite this